ClinStar, a CRO providing clinical research services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, is opening a new, East Coast regional office in the U.S.

As a second U.S. location to its headquarters in San Francisco, Calif., ClinStar's new office is in Durham, N.C. The new facility was chosen in large part because of its flexibility to accommodate the company's future growth.

According to President and CEO David Passov, "This is the realization of a major long-term business goal for ClinStar. Our new office further solidifies our commitment to offer our clients the local expertise and knowledge they need to successfully conduct clinical trials in Russia and Eastern Europe while ensuring our business operates in accordance with the proven business and management principles practiced in the West."